name,category,termsATG2 autophagy related 2 homolog B (S. cerevisiae),COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
ATG2 autophagy related 2 homolog B (S. cerevisiae),INTERPRO[450013854$IPR015412:ATG2, C-terminal]
ATG2 autophagy related 2 homolog B (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
ATG2 autophagy related 2 homolog B (S. cerevisiae),UP_SEQ_FEATURE[850006877$chain:Autophagy-related protein 2 homolog B, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
ATPase family, AAA domain containing 3C,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site]
ATPase family, AAA domain containing 3C,SMART[760000335$SM00382:AAA]
ATPase family, AAA domain containing 3C,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790001063$nucleotide-binding]
ATPase family, AAA domain containing 3C,UP_SEQ_FEATURE[850006789$chain:ATPase family AAA domain-containing protein 3C, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP]
CCR4-NOT transcription complex, subunit 2,INTERPRO[450006648$IPR007282:NOT2/NOT3/NOT5]
CCR4-NOT transcription complex, subunit 2,KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
CCR4-NOT transcription complex, subunit 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
CCR4-NOT transcription complex, subunit 2,UP_SEQ_FEATURE[850010112$chain:CCR4-NOT transcription complex subunit 2, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
COMM domain containing 5,INTERPRO[450008972$IPR009886:HCaRG, 450016234$IPR017920:COMM domain]
COMM domain containing 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism]
COMM domain containing 5,UP_SEQ_FEATURE[850012277$chain:COMM domain-containing protein 5, 850103407$domain:COMM, 850117294$sequence conflict, 850117295$sequence variant]
COX assembly mitochondrial protein homolog (S. cerevisiae),INTERPRO[450012488$IPR013892:Cytochrome c oxidase biogenesis protein Cmc1-like]
COX assembly mitochondrial protein homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000371$copper, 790000937$metal-binding, 790000969$mitochondrion]
COX assembly mitochondrial protein homolog (S. cerevisiae),UP_SEQ_FEATURE[850012660$chain:COX assembly mitochondrial protein homolog, 850106258$modified residue, 850117294$sequence conflict]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,INTERPRO[450000537$IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,PIR_SUPERFAMILY[630026222$PIRSF034443:PIRSF034443]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001212$polymorphism, 790001339$rna-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,UP_SEQ_FEATURE[850041114$chain:Probable ATP-dependent RNA helicase DDX49, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif]
DIS3 mitotic control homolog (S. cerevisiae),COG_ONTOLOGY[90000115$Transcription]
DIS3 mitotic control homolog (S. cerevisiae),INTERPRO[450001682$IPR001900:Ribonuclease II and R, 450006016$IPR006596:Nucleotide binding protein, PINc]
DIS3 mitotic control homolog (S. cerevisiae),KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
DIS3 mitotic control homolog (S. cerevisiae),PIR_SUPERFAMILY[630006771$PIRSF006825:mitotic control protein Dis3]
DIS3 mitotic control homolog (S. cerevisiae),SMART[760000582$SM00670:PINc]
DIS3 mitotic control homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000523$exonuclease, 790000526$exosome, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001212$polymorphism, 790001339$rna-binding, 790001345$rrna processing]
DIS3 mitotic control homolog (S. cerevisiae),UP_SEQ_FEATURE[850018279$chain:Exosome complex exonuclease RRP44, 850104997$domain:PINc, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),BBID[10000076$56.Macrophage_regulation_of_CD4+T_cells]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038916$hsa05322:Systemic lupus erythematosus]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),OMIM_DISEASE[520002972$Lupus erythematosus, systemic, susceptibility, 520003622$Neutropenia, alloimmune neonatal, 520005034$Viral infections, recurrent]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),PIR_SUPERFAMILY[630002118$PIRSF001980:Fc gamma receptor III]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SMART[760000357$SM00409:IG]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000761$igg-binding protein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),UP_SEQ_FEATURE[850029060$chain:Low affinity immunoglobulin gamma Fc region receptor III-A, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
IKAROS family zinc finger 1 (Ikaros),COG_ONTOLOGY[90000073$General function prediction only]
IKAROS family zinc finger 1 (Ikaros),INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
IKAROS family zinc finger 1 (Ikaros),OMIM_DISEASE[520002832$Leukemia, acute lymphoblastic]
IKAROS family zinc finger 1 (Ikaros),SMART[760000323$SM00355:ZnF_C2H2]
IKAROS family zinc finger 1 (Ikaros),SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000258$cell cycle, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000466$dna-binding, 790000811$isopeptide bond, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
IKAROS family zinc finger 1 (Ikaros),UP_SEQ_FEATURE[850015926$chain:DNA-binding protein Ikaros, 850102576$compositionally biased region:Poly-Leu, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850106258$modified residue, 850114251$region of interest:Required for binding PP1CC, 850114261$region of interest:Required for both high-affinity DNA binding and pericentromeric heterochromatin localization, 850117294$sequence conflict, 850118520$site:Required for both pericentromeric heterochromatin localization and complete DNA binding, 850118521$site:Required for both pericentromeric heterochromatin localization and DNA binding, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6]
IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae),INTERPRO[450000192$IPR000223:Peptidase S26A, signal peptidase I, 450010014$IPR011056:Peptidase S24, S26A, S26B and S26C, beta-ribbon domain, 450017991$IPR019756:Peptidase S26A, signal peptidase I, serine active site, 450017992$IPR019757:Peptidase S26A, signal peptidase I, lysine active site, 450017993$IPR019758:Peptidase S26A, signal peptidase I, conserved site, 450017994$IPR019759:Peptidase S24, S26A and S26B, conserved region]
IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae),PIR_SUPERFAMILY[630001348$PIRSF001208:signal peptidase I]
IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001252$Protease]
IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae),UP_SEQ_FEATURE[850031973$chain:Mitochondrial inner membrane protease subunit 1]
Kv channel interacting protein 2,COG_ONTOLOGY[90000111$Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
Kv channel interacting protein 2,INTERPRO[450000986$IPR001125:Recoverin, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
Kv channel interacting protein 2,SMART[760000046$SM00054:EFh]
Kv channel interacting protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001304$repeat, 790001558$transport, 790001631$voltage-gated channel]
Kv channel interacting protein 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850027659$chain:Kv channel-interacting protein 2, 850103582$domain:EF-hand 1; degenerate, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850112463$region of interest:Interaction with KCND2, 850117294$sequence conflict, 850118574$splice variant]
Ly6/neurotoxin 1,INTERPRO[450001358$IPR001526:CD59 antigen, 450014439$IPR016054:Ly-6 antigen / uPA receptor -like, 450016648$IPR018363:CD59 antigen, conserved site]
Ly6/neurotoxin 1,PIR_SUPERFAMILY[630002157$PIRSF002021:Ly-6-like protein]
Ly6/neurotoxin 1,SMART[760000116$SM00134:LU]
Ly6/neurotoxin 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000881$lipoprotein, 790000919$membrane, 790001363$Secreted, 790001405$signal]
Ly6/neurotoxin 1,UP_SEQ_FEATURE[850029207$chain:Ly-6/neurotoxin-like protein 1, 850059126$chain:Secreted Ly-6/uPAR-related protein 2, 850102883$disulfide bond, 850105609$domain:UPAR/Ly6, 850105852$helix, 850105860$lipid moiety-binding region:GPI-anchor amidated glycine, 850109701$propeptide:Removed in mature form, 850117814$signal peptide, 850118575$strand, 850118624$turn]
PCTAIRE protein kinase 3,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450009944$IPR010916:TonB box, conserved site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
PCTAIRE protein kinase 3,SMART[760000193$SM00220:S_TKc]
PCTAIRE protein kinase 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase]
PCTAIRE protein kinase 3,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010438$chain:Cell division protein kinase 18, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
POU class 5 homeobox 1B,INTERPRO[450000280$IPR000327:POU-specific, 450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450012446$IPR013847:POU, 450014024$IPR015585:POU domain class 5, 450016278$IPR017970:Homeobox, conserved site]
POU class 5 homeobox 1B,PIR_SUPERFAMILY[630002736$PIRSF002628:transcription factor Oct-3]
POU class 5 homeobox 1B,SMART[760000320$SM00352:POU, 760000341$SM00389:HOX]
POU class 5 homeobox 1B,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
POU class 5 homeobox 1B,UP_SEQ_FEATURE[850053794$chain:Putative POU domain, class 5, transcription factor 1B, 850102927$DNA-binding region:Homeobox, 850105054$domain:POU-specific, 850117294$sequence conflict]
RAB40C, member RAS oncogene family,INTERPRO[450001330$IPR001496:SOCS protein, C-terminal, 450001599$IPR001806:Ras GTPase, 450003146$IPR003579:Ras small GTPase, Rab type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
RAB40C, member RAS oncogene family,OMIM_DISEASE[520002597$Identification of ten loci associated with height highlights new biological pathways in human growth]
RAB40C, member RAS oncogene family,PIR_SUPERFAMILY[630029084$PIRSF037502:Ras-related protein Rab-40]
RAB40C, member RAS oncogene family,SMART[760000149$SM00175:RAB, 760000225$SM00253:SOCS]
RAB40C, member RAS oncogene family,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790001063$nucleotide-binding, 790001100$palmitate, 790001236$prenylation, 790001593$ubl conjugation pathway]
RAB40C, member RAS oncogene family,UP_SEQ_FEATURE[850056803$chain:Ras-related protein Rab-40C, 850105375$domain:SOCS box, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP]
RAS-like, family 12,INTERPRO[450001599$IPR001806:Ras GTPase, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
RAS-like, family 12,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000639$gtp-binding, 790001063$nucleotide-binding]
RAS-like, family 12,UP_SEQ_FEATURE[850056732$chain:Ras-like protein family member 12, 850105852$helix, 850106296$nucleotide phosphate-binding region:GTP, 850118575$strand]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450006446$IPR007052:CS domain, 450007054$IPR007699:SGS, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450011749$IPR013105:Tetratricopeptide TPR2, 450015774$IPR017447:CS, 450017972$IPR019734:Tetratricopeptide repeat]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),KEGG_PATHWAY[470038863$hsa04621:NOD-like receptor signaling pathway]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),PIR_SUPERFAMILY[630028306$PIRSF036827:PIRSF036827]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),SMART[760000020$SM00028:TPR]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001304$repeat, 790001537$tpr repeat, 790001593$ubl conjugation pathway]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),UP_SEQ_FEATURE[850062991$chain:Suppressor of G2 allele of SKP1 homolog, 850103417$domain:CS, 850105345$domain:SGS, 850105852$helix, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand]
SSU72 RNA polymerase II CTD phosphatase homolog (S. cerevisiae),INTERPRO[450005562$IPR006130:Aspartate/ornithine carbamoyltransferase, 450006215$IPR006811:RNA polymerase II subunit A]
SSU72 RNA polymerase II CTD phosphatase homolog (S. cerevisiae),PIR_SUPERFAMILY[630014444$PIRSF017782:RNA polymerase II subunit A C-terminal domain phosphatase SSU72]
SSU72 RNA polymerase II CTD phosphatase homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000988$mrna processing, 790001065$nucleus, 790001261$protein phosphatase]
SSU72 RNA polymerase II CTD phosphatase homolog (S. cerevisiae),UP_SEQ_FEATURE[850058370$chain:RNA polymerase II subunit A C-terminal domain phosphatase SSU72, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant]
TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450005985$IPR006565:Bromodomain transcription factor, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa,SMART[760000221$SM00249:PHD, 760000513$SM00576:BTP]
TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa,UP_SEQ_FEATURE[850065455$chain:Transcription initiation factor TFIID subunit 3, 850102554$compositionally biased region:Lys-rich, 850102572$compositionally biased region:Poly-Glu, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118877$zinc finger region:PHD-type]
TatD DNase domain containing 1,INTERPRO[450000991$IPR001130:Deoxyribonuclease, TatD-related, 450010991$IPR012278:Deoxyribonuclease, TatD Mg-dependent, 450014394$IPR015992:Deoxyribonuclease, TatD, 450016513$IPR018228:Deoxyribonuclease, TatD-related, conserved site]
TatD DNase domain containing 1,PIR_SUPERFAMILY[630005834$PIRSF005902:DNase_TatD, 630005835$PIRSF005902:Mg-dependent DNase, TatD type]
TatD DNase domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus]
TatD DNase domain containing 1,UP_SEQ_FEATURE[850050480$chain:Putative deoxyribonuclease TATDN1, 850117294$sequence conflict, 850118574$splice variant]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8),INTERPRO[450000667$IPR000772:Ricin B lectin, 450001029$IPR001173:Glycosyl transferase, family 2]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8),KEGG_PATHWAY[470038768$hsa00512:O-Glycan biosynthesis]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8),SMART[760000403$SM00458:RICIN]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8),SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000848$Lectin, 790000906$manganese, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8),UP_SEQ_FEATURE[850043291$chain:Probable polypeptide N- acetylgalactosaminyltransferase 8, 850102883$disulfide bond, 850105188$domain:Ricin B-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850111204$region of interest:Catalytic subdomain A, 850111205$region of interest:Catalytic subdomain B, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
activating signal cointegrator 1 complex subunit 1,INTERPRO[450003602$IPR004087:K Homology, 450003603$IPR004088:K Homology, type 1, 450008322$IPR009210:Predicted eukaryotic LigT, 450016411$IPR018111:K Homology, type 1, subgroup]
activating signal cointegrator 1 complex subunit 1,PIR_SUPERFAMILY[630020619$PIRSF027019:Euk_LigT, 630020620$PIRSF027019:phosphoesterase, eukaryotic LigT type]
activating signal cointegrator 1 complex subunit 1,SMART[760000291$SM00322:KH]
activating signal cointegrator 1 complex subunit 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
activating signal cointegrator 1 complex subunit 1,UP_SEQ_FEATURE[850003662$chain:Activating signal cointegrator 1 complex subunit 1, 850104520$domain:KH, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
beta-carotene oxygenase 2,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
beta-carotene oxygenase 2,INTERPRO[450003805$IPR004294:Carotenoid oxygenase]
beta-carotene oxygenase 2,PIR_SUPERFAMILY[630012792$PIRSF016018:carotenoid oxygenase, 630030702$PIRSF500488:beta,beta-carotene 9',10'-dioxygenase]
beta-carotene oxygenase 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000437$dioxygenase, 790000802$iron, 790000937$metal-binding, 790001092$oxidoreductase, 790001212$polymorphism]
beta-carotene oxygenase 2,UP_SEQ_FEATURE[850007512$chain:Beta,beta-carotene 9',10'-oxygenase, 850106003$metal ion-binding site:Iron, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
blocked early in transport 1 homolog (S. cerevisiae)-like,INTERPRO[450000626$IPR000727:Target SNARE coiled-coil region]
blocked early in transport 1 homolog (S. cerevisiae)-like,KEGG_PATHWAY[470038838$hsa04130:SNARE interactions in vesicular transport]
blocked early in transport 1 homolog (S. cerevisiae)-like,SMART[760000348$SM00397:t_SNARE]
blocked early in transport 1 homolog (S. cerevisiae)-like,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001266$protein transport, 790001555$transmembrane, 790001558$transport]
blocked early in transport 1 homolog (S. cerevisiae)-like,UP_SEQ_FEATURE[850007497$chain:BET1-like protein, 850105459$domain:t-SNARE coiled-coil homology, 850106258$modified residue, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
carbohydrate (chondroitin 6) sulfotransferase 3,INTERPRO[450000753$IPR000863:Sulfotransferase, 450014790$IPR016469:Carbohydrate sulfotransferase]
carbohydrate (chondroitin 6) sulfotransferase 3,KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis]
carbohydrate (chondroitin 6) sulfotransferase 3,OMIM_DISEASE[520002383$Humerospinal dysostosis, 520004661$Spondyloepiphyseal dysplasia, Omani type]
carbohydrate (chondroitin 6) sulfotransferase 3,PIR_SUPERFAMILY[630005810$PIRSF005883:carbohydrate sulfotransferase, 630005811$PIRSF005883:Carbohydrate_sulfotransferase]
carbohydrate (chondroitin 6) sulfotransferase 3,SP_PIR_KEYWORDS[790000232$carbohydrate metabolism, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
carbohydrate (chondroitin 6) sulfotransferase 3,UP_SEQ_FEATURE[850009412$chain:Carbohydrate sulfotransferase 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106312$nucleotide phosphate-binding region:PAPS, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
centrosomal protein 164kDa,INTERPRO[450001055$IPR001202:WW/Rsp5/WWP]
centrosomal protein 164kDa,SMART[760000401$SM00456:WW]
centrosomal protein 164kDa,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000315$chromosomal protein, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000452$DNA damage, 790000459$dna repair, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
centrosomal protein 164kDa,UP_SEQ_FEATURE[850010692$chain:Centrosomal protein of 164 kDa, 850102507$compositionally biased region:Glu-rich, 850102554$compositionally biased region:Lys-rich, 850105731$domain:WW, 850106258$modified residue, 850106259$mutagenesis site, 850112110$region of interest:Interaction with ATRIP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chaperonin containing TCP1, subunit 3 (gamma),INTERPRO[450001946$IPR002194:Chaperonin TCP-1, conserved site, 450002152$IPR002423:Chaperonin Cpn60/TCP-1, 450011398$IPR012719:T-complex protein 1, gamma subunit, 450016306$IPR017998:Chaperone, tailless complex polypeptide 1]
chaperonin containing TCP1, subunit 3 (gamma),PIR_SUPERFAMILY[630002698$PIRSF002584:molecular chaperone t-complex-type]
chaperonin containing TCP1, subunit 3 (gamma),SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000288$Chaperone, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000976$molecular chaperone, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism]
chaperonin containing TCP1, subunit 3 (gamma),UP_SEQ_FEATURE[850063420$chain:T-complex protein 1 subunit gamma, 850102883$disulfide bond, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
chemokine (C motif) ligand 1,INTERPRO[450001604$IPR001811:Small chemokine, interleukin-8-like, 450007440$IPR008105:Lymphotactin precursor]
chemokine (C motif) ligand 1,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway]
chemokine (C motif) ligand 1,SMART[760000172$SM00199:SCY]
chemokine (C motif) ligand 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000447$disulfide bond, 790001363$Secreted, 790001405$signal]
chemokine (C motif) ligand 1,UP_SEQ_FEATURE[850029252$chain:Lymphotactin, 850102883$disulfide bond, 850105852$helix, 850117814$signal peptide, 850118575$strand]
chitinase 1 (chitotriosidase),INTERPRO[450001076$IPR001223:Glycoside hydrolase, family 18, catalytic domain, 450001403$IPR001579:Glycoside hydrolase, chitinase active site, 450002273$IPR002557:Chitin binding protein, peritrophin-A, 450010425$IPR011583:Chitinase II, 450012395$IPR013781:Glycoside hydrolase, subgroup, catalytic core]
chitinase 1 (chitotriosidase),KEGG_PATHWAY[470038770$hsa00520:Amino sugar and nucleotide sugar metabolism]
chitinase 1 (chitotriosidase),OMIM_DISEASE[520000982$Chitotriosidase deficiency]
chitinase 1 (chitotriosidase),PIR_SUPERFAMILY[630001210$PIRSF001061:chitinase-like protein]
chitinase 1 (chitotriosidase),SMART[760000437$SM00494:ChtBD2, 760000551$SM00636:Glyco_18]
chitinase 1 (chitotriosidase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000232$carbohydrate metabolism, 790000293$Chitin degradation, 790000294$Chitin-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000617$glycosidase, 790000743$hydrolase, 790000897$lysosome, 790001212$polymorphism, 790001216$polysaccharide degradation, 790001363$Secreted, 790001405$signal]
chitinase 1 (chitotriosidase),UP_SEQ_FEATURE[850000131$active site:Proton donor, 850011055$chain:Chitotriosidase-1, 850102883$disulfide bond, 850103339$domain:Chitin-binding type-2, 850105852$helix, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118624$turn]
chromosome 1 open reading frame 159,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
chromosome 1 open reading frame 159,UP_SEQ_FEATURE[850073608$chain:Uncharacterized protein C1orf159, 850102586$compositionally biased region:Pro-rich, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide, 850118574$splice variant, 850118623$transmembrane region]
chromosome 10 open reading frame 32,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 10 open reading frame 32,UP_SEQ_FEATURE[850098220$chain:UPF0693 protein C10orf32, 850106258$modified residue]
chromosome 11 open reading frame 30,INTERPRO[450004946$IPR005491:ENT]
chromosome 11 open reading frame 30,OMIM_DISEASE[520001992$Genome-wide assocation defines more than 30 distinct susceptibility loci for Crohn's disease]
chromosome 11 open reading frame 30,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000616$glycoprotein, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
chromosome 11 open reading frame 30,UP_SEQ_FEATURE[850045742$chain:Protein EMSY, 850102485$compositionally biased region:Gln-rich, 850102581$compositionally biased region:Poly-Ser, 850102597$compositionally biased region:Ser-rich, 850102605$compositionally biased region:Thr-rich, 850103716$domain:ENT, 850105829$glycosylation site:O-linked (GlcNAc), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112132$region of interest:Interaction with BRCA2, 850113057$region of interest:Interaction with ZMYND11, 850118574$splice variant, 850118575$strand]
chromosome 12 open reading frame 42,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 12 open reading frame 42,UP_SEQ_FEATURE[850073049$chain:Uncharacterized protein C12orf42, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 14 open reading frame 129,INTERPRO[450007310$IPR007967:Protein of unknown function DUF727]
chromosome 14 open reading frame 129,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm]
chromosome 14 open reading frame 129,UP_SEQ_FEATURE[850022508$chain:GSK3-beta interaction protein, 850105852$helix, 850106259$mutagenesis site, 850112379$region of interest:Interaction with GSK3B, 850117294$sequence conflict, 850118575$strand]
chromosome 14 open reading frame 159,INTERPRO[450008991$IPR009906:Protein of unknown function DUF1445, 450015455$IPR017135:Uncharacterised protein family UPF0317, mitochondria]
chromosome 14 open reading frame 159,PIR_SUPERFAMILY[630028722$PIRSF037204:UCP037204, 630028723$PIRSF037204:uncharacterized conserved protein]
chromosome 14 open reading frame 159,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001550$transit peptide]
chromosome 14 open reading frame 159,UP_SEQ_FEATURE[850094009$chain:UPF0317 protein C14orf159, mitochondrial, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
chromosome 16 open reading frame 5,INTERPRO[450006048$IPR006629:LPS-induced tumor necrosis factor alpha factor, 450017821$IPR019584:Zinc finger region, LITAF-like]
chromosome 16 open reading frame 5,SMART[760000621$SM00714:LITAF]
chromosome 16 open reading frame 5,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 16 open reading frame 5,UP_SEQ_FEATURE[850028907$chain:LITAF-like protein, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict]
chromosome 9 open reading frame 16,INTERPRO[450004832$IPR005374:Uncharacterised protein family UPF0184]
chromosome 9 open reading frame 16,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 9 open reading frame 16,UP_SEQ_FEATURE[850088886$chain:UPF0184 protein C9orf16, 850106258$modified residue, 850117294$sequence conflict]
chromosome 9 open reading frame 24,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 9 open reading frame 24,UP_SEQ_FEATURE[850074539$chain:Uncharacterized protein C9orf24, 850117295$sequence variant, 850118574$splice variant]
claspin homolog (Xenopus laevis),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000258$cell cycle, 790000315$chromosomal protein, 790000344$coiled coil, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
claspin homolog (Xenopus laevis),UP_SEQ_FEATURE[850011562$chain:Claspin, 850106258$modified residue, 850106259$mutagenesis site, 850115775$repeat:CKB motif 1, 850115776$repeat:CKB motif 2, 850115777$repeat:CKB motif 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
collagen, type II, alpha 1,INTERPRO[450000772$IPR000885:Fibrillar collagen, C-terminal, 450000878$IPR001007:von Willebrand factor, type C, 450007490$IPR008160:Collagen triple helix repeat]
collagen, type II, alpha 1,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038854$hsa04512:ECM-receptor interaction]
collagen, type II, alpha 1,OMIM_DISEASE[520000101$Achondrogenesis-hypochondrogenesis, type II, 520000393$Arthroophthalmopathy, progressive, 520000493$Avascular necrosis of the femoral head, 520001782$Epiphyseal dysplasia, multiple, with, 520001784$Epiphyseal dysplasia, multiple, with myopia and deafness, 520002747$Kniest dysplasia, 520002804$Legg-Calve-Perthes disease, 520003803$Osteoarthritis with mild chondrodysplasia, 520003852$Otospondylomegaepiphyseal dysplasia, 520004030$Platyspondylic skeletal dysplasia, Torrance type, 520004421$SED congenita, 520004422$SED, Namaqualand type, 520004517$SMD, 520004518$SMED Strudwick type, 520004663$Spondyloperipheral dysplasia, 520004695$Stickler sydrome, type I, nonsyndromic ocular, 520004696$Stickler syndrome, type I, 520005045$Vitreoretinopathy with phalangeal epiphyseal dysplasia]
collagen, type II, alpha 1,PIR_SUPERFAMILY[630002384$PIRSF002255:collagen alpha 1(I) chain]
collagen, type II, alpha 1,SMART[760000030$SM00038:COLFI, 760000187$SM00214:VWC]
collagen, type II, alpha 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000250$cartilage, 790000252$cataract, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000415$deafness, 790000445$direct protein sequencing, 790000446$disease mutation, 790000474$dwarfism, 790000530$extracellular matrix, 790000616$glycoprotein, 790000745$hydroxylation, 790000746$hydroxylysine, 790000747$hydroxyproline, 790001212$polymorphism, 790001289$pyroglutamic acid, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001446$stickler syndrome, 790001565$trimer, 790001568$triple helix]
collagen, type II, alpha 1,UP_SEQ_FEATURE[850011231$chain:Chondrocalcin, 850012176$chain:Collagen alpha-1(II) chain, 850103779$domain:Fibrillar collagen NC1, 850105643$domain:VWFC, 850105770$glycosylation site:N-linked (GlcNAc...), 850105818$glycosylation site:O-linked (Gal...), 850106258$modified residue, 850109670$propeptide:N-terminal propeptide, 850113762$region of interest:Nonhelical region (C-terminal), 850114937$region of interest:Triple-helical region, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118098$site:Cleavage; by procollagen C-endopeptidase, 850118099$site:Cleavage; by procollagen N-endopeptidase, 850118574$splice variant, 850118575$strand]
cysteine and glycine-rich protein 3 (cardiac LIM protein),INTERPRO[450001575$IPR001781:Zinc finger, LIM-type]
cysteine and glycine-rich protein 3 (cardiac LIM protein),OMIM_DISEASE[520000775$Cardiomyopathy, dilated, 1M, 520000799$Cardiomyopathy, familial hypertrophic, 12]
cysteine and glycine-rich protein 3 (cardiac LIM protein),PIR_SUPERFAMILY[630014596$PIRSF017937:cysteine and glycine-rich protein]
cysteine and glycine-rich protein 3 (cardiac LIM protein),SMART[760000114$SM00132:LIM]
cysteine and glycine-rich protein 3 (cardiac LIM protein),SP_PIR_KEYWORDS[790000002$3d-structure, 790000245$Cardiomyopathy, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000428$developmental protein, 790000434$differentiation, 790000446$disease mutation, 790000864$LIM domain, 790000937$metal-binding, 790001001$myogenesis, 790001065$nucleus, 790001304$repeat, 790001648$zinc]
cysteine and glycine-rich protein 3 (cardiac LIM protein),UP_SEQ_FEATURE[850013239$chain:Cysteine and glycine-rich protein 3, 850102517$compositionally biased region:Gly-rich, 850104717$domain:LIM zinc-binding 1, 850104718$domain:LIM zinc-binding 2, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118575$strand, 850118624$turn]
cytochrome P450, family 19, subfamily A, polypeptide 1,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 19, subfamily A, polypeptide 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 19, subfamily A, polypeptide 1,KEGG_PATHWAY[470038739$hsa00140:Steroid hormone biosynthesis, 470038740$hsa00150:Androgen and estrogen metabolism]
cytochrome P450, family 19, subfamily A, polypeptide 1,OMIM_DISEASE[520000368$Aromatase deficiency, 520000369$Aromatase excess syndrome, 520004150$Pseudohermaphroditism, female, due to placental aromatase deficiency]
cytochrome P450, family 19, subfamily A, polypeptide 1,PIR_SUPERFAMILY[630000062$PIRSF000049:cytochrome P450 CYP19]
cytochrome P450, family 19, subfamily A, polypeptide 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000314$chromoprotein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000488$electron transfer, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000984$Monooxygenase, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism, 790001440$Steroid biosynthesis, 790001556$transmembrane protein]
cytochrome P450, family 19, subfamily A, polypeptide 1,UP_SEQ_FEATURE[850013664$chain:Cytochrome P450 19A1, 850105852$helix, 850106026$metal ion-binding site:Iron (heme axial ligand), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
cytoskeleton associated protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000258$cell cycle, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000960$microtubule, 790001162$phosphoprotein, 790001212$polymorphism]
cytoskeleton associated protein 2,UP_SEQ_FEATURE[850014066$chain:Cytoskeleton-associated protein 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dedicator of cytokinesis 8,INTERPRO[450009747$IPR010703:Dedicator of cytokinesis]
dedicator of cytokinesis 8,OMIM_DISEASE[520003160$Mental retardation, autosomal dominant 2]
dedicator of cytokinesis 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor, 790001162$phosphoprotein, 790001212$polymorphism]
dedicator of cytokinesis 8,UP_SEQ_FEATURE[850014452$chain:Dedicator of cytokinesis protein 8, 850103522$domain:DHR-1, 850103523$domain:DHR-2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dehydrogenase E1 and transketolase domain containing 1,INTERPRO[450000890$IPR001017:Dehydrogenase, E1 component, 450004931$IPR005475:Transketolase, central region, 450010434$IPR011603:2-oxoglutarate dehydrogenase, E1 component]
dehydrogenase E1 and transketolase domain containing 1,PIR_SUPERFAMILY[630000186$PIRSF000157:2-oxoglutarate dehydrogenase, E1 component, 630000187$PIRSF000157:Oxoglu_dh_E1]
dehydrogenase E1 and transketolase domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000615$glycolysis, 790000969$mitochondrion, 790001092$oxidoreductase, 790001212$polymorphism, 790001503$thiamine pyrophosphate, 790001550$transit peptide]
dehydrogenase E1 and transketolase domain containing 1,UP_SEQ_FEATURE[850040661$chain:Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
delta-like 2 homolog (Drosophila),INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001280$IPR001438:EGF-like, type 2, 450001663$IPR001881:EGF-like calcium-binding, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
delta-like 2 homolog (Drosophila),SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF]
delta-like 2 homolog (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
delta-like 2 homolog (Drosophila),UP_SEQ_FEATURE[850045565$chain:Protein delta homolog 2, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850103693$domain:EGF-like 5; calcium-binding, 850103696$domain:EGF-like 6; calcium-binding, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
dual specificity phosphatase 5,INTERPRO[450000291$IPR000340:Dual specificity phosphatase, catalytic domain, 450000292$IPR000340:Protein-tyrosine phosphatase, dual specificity, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450001562$IPR001763:Rhodanese-like, 450007621$IPR008343:MAP kinase phosphatase, 450012969$IPR014393:Dual specificity protein phosphatase (MAP kinase phosphatase), 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
dual specificity phosphatase 5,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway]
dual specificity phosphatase 5,PIR_SUPERFAMILY[630001087$PIRSF000939:dual specificity protein phosphatase (MAP kinase phosphatase), 630001088$PIRSF000939:MAPK_Ptase]
dual specificity phosphatase 5,SMART[760000169$SM00195:DSPc, 760000395$SM00450:RHOD]
dual specificity phosphatase 5,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000743$hydrolase, 790001065$nucleus, 790001212$polymorphism, 790001261$protein phosphatase]
dual specificity phosphatase 5,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850016440$chain:Dual specificity protein phosphatase 5, 850102573$compositionally biased region:Poly-Gly, 850105184$domain:Rhodanese, 850105593$domain:Tyrosine-protein phosphatase, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118575$strand]
enabled homolog (Drosophila),INTERPRO[450000132$IPR000156:Ran Binding Protein 1, 450000597$IPR000697:EVH1, 450010818$IPR011993:Pleckstrin homology-type, 450013334$IPR014885:VASP tetramerisation]
enabled homolog (Drosophila),KEGG_PATHWAY[470038881$hsa04810:Regulation of actin cytoskeleton]
enabled homolog (Drosophila),SMART[760000141$SM00160:RanBD, 760000406$SM00461:WH1]
enabled homolog (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000019$actin-binding, 790000053$alternative splicing, 790000263$cell junction, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001304$repeat, 790001399$sh3-binding, 790001475$synapse]
enabled homolog (Drosophila),UP_SEQ_FEATURE[850045744$chain:Protein enabled homolog, 850102586$compositionally biased region:Pro-rich, 850105697$domain:WH1, 850105852$helix, 850106258$modified residue, 850110773$region of interest:9 X 5 AA tandem repeats of [LMQ]-E-[QR]- E-[QR], 850111645$region of interest:EVH2, 850111646$region of interest:EVH2 block A, 850111647$region of interest:EVH2 block B, 850111648$region of interest:EVH2 block C, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117294$sequence conflict, 850117535$short sequence motif:KLKR, 850118574$splice variant, 850118575$strand, 850118624$turn]
family with sequence similarity 19 (chemokine (C-C motif)-like), member A4,SP_PIR_KEYWORDS[790000356$complete proteome, 790001363$Secreted, 790001405$signal]
family with sequence similarity 19 (chemokine (C-C motif)-like), member A4,UP_SEQ_FEATURE[850045945$chain:Protein FAM19A4, 850117814$signal peptide]
flavin containing monooxygenase 4,INTERPRO[450000835$IPR000960:Flavin-containing monooxygenase FMO, 450002002$IPR002256:Flavin-containing monooxygenase (FMO) 4, 450010924$IPR012143:Dimethylaniline monooxygenase, N-oxide-forming]
flavin containing monooxygenase 4,KEGG_PATHWAY[470038809$hsa00982:Drug metabolism]
flavin containing monooxygenase 4,PIR_SUPERFAMILY[630000386$PIRSF000332:dimethylaniline monooxygenase (N-oxide-forming), 630000387$PIRSF000332:FMO]
flavin containing monooxygenase 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000537$FAD, 790000559$Flavoprotein, 790000919$membrane, 790000959$microsome, 790000984$Monooxygenase, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001555$transmembrane, 790001556$transmembrane protein]
flavin containing monooxygenase 4,UP_SEQ_FEATURE[850015181$chain:Dimethylaniline monooxygenase [N-oxide- forming] 4, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850106307$nucleotide phosphate-binding region:NADP, 850117295$sequence variant, 850118623$transmembrane region]
flavin containing monooxygenase 5,INTERPRO[450000835$IPR000960:Flavin-containing monooxygenase FMO, 450002003$IPR002257:Flavin-containing monooxygenase (FMO) 5, 450010924$IPR012143:Dimethylaniline monooxygenase, N-oxide-forming]
flavin containing monooxygenase 5,KEGG_PATHWAY[470038809$hsa00982:Drug metabolism]
flavin containing monooxygenase 5,PIR_SUPERFAMILY[630000386$PIRSF000332:dimethylaniline monooxygenase (N-oxide-forming), 630000387$PIRSF000332:FMO]
flavin containing monooxygenase 5,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000537$FAD, 790000559$Flavoprotein, 790000919$membrane, 790000953$methylation, 790000959$microsome, 790000984$Monooxygenase, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001555$transmembrane]
flavin containing monooxygenase 5,UP_SEQ_FEATURE[850015182$chain:Dimethylaniline monooxygenase [N-oxide- forming] 5, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850106307$nucleotide phosphate-binding region:NADP, 850117294$sequence conflict, 850117295$sequence variant]
gamma-glutamyl cyclotransferase,INTERPRO[450008399$IPR009288:AIG2-like, 450016251$IPR017939:Gamma-glutamylcyclotransferase]
gamma-glutamyl cyclotransferase,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism]
gamma-glutamyl cyclotransferase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000025$Acyltransferase, 790000053$alternative splicing, 790000356$complete proteome, 790001547$transferase]
gamma-glutamyl cyclotransferase,UP_SEQ_FEATURE[850020541$chain:Gamma-glutamylcyclotransferase, 850105852$helix, 850106259$mutagenesis site, 850118574$splice variant, 850118575$strand, 850118624$turn]
glutamine and serine rich 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
glutamine and serine rich 1,UP_SEQ_FEATURE[850021637$chain:Glutamine and serine-rich protein 1, 850102485$compositionally biased region:Gln-rich, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
glutathione S-transferase omega 2,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
glutathione S-transferase omega 2,INTERPRO[450003562$IPR004045:Glutathione S-transferase, N-terminal, 450004901$IPR005442:Glutathione S-transferase, omega-class, 450009996$IPR010987:Glutathione S-transferase, C-terminal-like, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
glutathione S-transferase omega 2,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
glutathione S-transferase omega 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001547$transferase]
glutathione S-transferase omega 2,UP_SEQ_FEATURE[850021808$chain:Glutathione S-transferase omega-2, 850104084$domain:GST C-terminal, 850104087$domain:GST N-terminal, 850117294$sequence conflict, 850117295$sequence variant]
glutathione reductase,BIOCARTA[30000117$h_freePathway:Free Radical Induced Apoptosis]
glutathione reductase,INTERPRO[450000708$IPR000815:Mercuric reductase, 450001169$IPR001327:Pyridine nucleotide-disulphide oxidoreductase, NAD-binding region, 450003614$IPR004099:Pyridine nucleotide-disulphide oxidoreductase, dimerisation, 450005747$IPR006322:Glutathione reductase, animal and bacterial, 450011674$IPR012999:Pyridine nucleotide-disulphide oxidoreductase, class I, active site, 450011694$IPR013027:FAD-dependent pyridine nucleotide-disulphide oxidoreductase]
glutathione reductase,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism]
glutathione reductase,OMIM_DISEASE[520002265$Hemolytic anemia due to glutathione reductase deficiency]
glutathione reductase,PIR_SUPERFAMILY[630000254$PIRSF000210:dihydrolipoamide dehydrogenase]
glutathione reductase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000050$alternative initiation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000537$FAD, 790000559$Flavoprotein, 790000701$homodimer, 790000969$mitochondrion, 790001008$nadp, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism, 790001302$Redox-active center, 790001303$redox-active disulfide, 790001550$transit peptide]
glutathione reductase,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850021757$chain:Glutathione reductase, mitochondrial, 850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
histone cluster 1, H2bi; histone cluster 1, H2bg; histone cluster 1, H2be; histone cluster 1, H2bf; histone cluster 1, H2bc,INTERPRO[450000478$IPR000558:Histone H2B, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold]
histone cluster 1, H2bi; histone cluster 1, H2bg; histone cluster 1, H2be; histone cluster 1, H2bf; histone cluster 1, H2bc,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
histone cluster 1, H2bi; histone cluster 1, H2bg; histone cluster 1, H2be; histone cluster 1, H2bf; histone cluster 1, H2bc,PIR_SUPERFAMILY[630002184$PIRSF002050:histone H2B]
histone cluster 1, H2bi; histone cluster 1, H2bg; histone cluster 1, H2be; histone cluster 1, H2bf; histone cluster 1, H2bc,SMART[760000373$SM00427:H2B]
histone cluster 1, H2bi; histone cluster 1, H2bg; histone cluster 1, H2be; histone cluster 1, H2bf; histone cluster 1, H2bc,SP_PIR_KEYWORDS[790000012$acetylation, 790000092$antibiotic, 790000100$Antimicrobial, 790000315$chromosomal protein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000449$DNA binding, 790000466$dna-binding, 790000811$isopeptide bond, 790000953$methylation, 790001058$nucleosome core, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
histone cluster 1, H2bi; histone cluster 1, H2bg; histone cluster 1, H2be; histone cluster 1, H2bf; histone cluster 1, H2bc,UP_SEQ_FEATURE[850024021$chain:Histone H2B type 1-C/E/F/G/I, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
hypothetical LOC100130633; zinc finger, MYM-type 6,INTERPRO[450009561$IPR010507:Zinc finger, MYM-type, 450010002$IPR011017:TRASH, 450010465$IPR011637:DoxX]
hypothetical LOC100130633; zinc finger, MYM-type 6,SMART[760000652$SM00746:TRASH]
hypothetical LOC100130633; zinc finger, MYM-type 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
hypothetical LOC100130633; zinc finger, MYM-type 6,UP_SEQ_FEATURE[850101420$chain:Zinc finger MYM-type protein 6, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118843$zinc finger region:MYM-type 1, 850118844$zinc finger region:MYM-type 2, 850118846$zinc finger region:MYM-type 3, 850118847$zinc finger region:MYM-type 4, 850118848$zinc finger region:MYM-type 5, 850118849$zinc finger region:MYM-type 6, 850118850$zinc finger region:MYM-type 7, 850118851$zinc finger region:MYM-type 8]
inositol 1,4,5-triphosphate receptor interacting protein,SP_PIR_KEYWORDS[790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001405$signal]
inositol 1,4,5-triphosphate receptor interacting protein,UP_SEQ_FEATURE[850026015$chain:Inositol 1,4,5-triphosphate receptor- interacting protein, 850102576$compositionally biased region:Poly-Leu, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117814$signal peptide]
insulin-degrading enzyme,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
insulin-degrading enzyme,INTERPRO[450001273$IPR001431:Peptidase M16, zinc-binding site, 450007211$IPR007863:Peptidase M16, C-terminal, 450010145$IPR011237:Peptidase M16, core, 450010592$IPR011765:Peptidase M16, N-terminal]
insulin-degrading enzyme,KEGG_PATHWAY[470038891$hsa05010:Alzheimer's disease]
insulin-degrading enzyme,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001063$nucleotide-binding, 790001212$polymorphism, 790001252$Protease, 790001648$zinc]
insulin-degrading enzyme,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850026146$chain:Insulin-degrading enzyme, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850106259$mutagenesis site, 850114716$region of interest:Substrate binding, 850114718$region of interest:Substrate binding exosite, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
interferon, alpha-inducible protein 6,INTERPRO[450008421$IPR009311:Interferon-induced 6-16]
interferon, alpha-inducible protein 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
interferon, alpha-inducible protein 6,UP_SEQ_FEATURE[850026393$chain:Interferon alpha-inducible protein 6, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant, 850118623$transmembrane region]
intermediate filament family orphan 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000788$Intermediate filament]
intermediate filament family orphan 1,UP_SEQ_FEATURE[850026601$chain:Intermediate filament family orphan 1, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850117294$sequence conflict, 850118574$splice variant]
keratin 77,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002681$IPR003054:Type II keratin, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site, 450016451$IPR018159:Spectrin/alpha-actinin]
keratin 77,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 77,SMART[760000132$SM00150:SPEC]
keratin 77,SP_PIR_KEYWORDS[790000326$citrullination, 790000344$coiled coil, 790000356$complete proteome, 790000788$Intermediate filament, 790000821$keratin, 790001162$phosphoprotein, 790001212$polymorphism]
keratin 77,UP_SEQ_FEATURE[850027203$chain:Keratin, type II cytoskeletal 1b, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118563$site:Stutter]
late cornified envelope 1C,INTERPRO[450002847$IPR003267:Small proline-rich]
late cornified envelope 1C,SP_PIR_KEYWORDS[790000356$complete proteome, 790000822$keratinization, 790001212$polymorphism]
late cornified envelope 1C,UP_SEQ_FEATURE[850028022$chain:Late cornified envelope protein 1C, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850117295$sequence variant]
leucine-rich repeats and immunoglobulin-like domains 2,COG_ONTOLOGY[90000070$Function unknown]
leucine-rich repeats and immunoglobulin-like domains 2,INTERPRO[450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011742$IPR013098:Immunoglobulin I-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
leucine-rich repeats and immunoglobulin-like domains 2,SMART[760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP, 760000356$SM00408:IGc2, 760000357$SM00409:IG]
leucine-rich repeats and immunoglobulin-like domains 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
leucine-rich repeats and immunoglobulin-like domains 2,UP_SEQ_FEATURE[850028453$chain:Leucine-rich repeats and immunoglobulin- like domains protein 2, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
leucine-rich repeats and immunoglobulin-like domains 3,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011742$IPR013098:Immunoglobulin I-set, 450012396$IPR013783:Immunoglobulin-like fold]
leucine-rich repeats and immunoglobulin-like domains 3,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP, 760000356$SM00408:IGc2, 760000357$SM00409:IG]
leucine-rich repeats and immunoglobulin-like domains 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000853$leucine-rich repeat, 790000919$membrane, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
leucine-rich repeats and immunoglobulin-like domains 3,UP_SEQ_FEATURE[850028454$chain:Leucine-rich repeats and immunoglobulin- like domains protein 3, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116314$repeat:LRR 15, 850116315$repeat:LRR 16, 850116316$repeat:LRR 17, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117814$signal peptide, 850118574$splice variant, 850118623$transmembrane region]
low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor),COG_ONTOLOGY[90000016$Carbohydrate transport and metabolism]
low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor),INTERPRO[450000026$IPR000033:Low-density lipoprotein receptor, YWTD repeat, 450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001663$IPR001881:EGF-like calcium-binding, 450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450010012$IPR011042:Six-bladed beta-propeller, TolB-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor),KEGG_PATHWAY[470038891$hsa05010:Alzheimer's disease]
low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor),PIR_SUPERFAMILY[630002102$PIRSF001963:LDL receptor-related protein]
low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor),SMART[760000117$SM00135:LY, 760000153$SM00179:EGF_CA, 760000155$SM00181:EGF, 760000166$SM00192:LDLa]
low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor),SP_PIR_KEYWORDS[790000002$3d-structure, 790000176$beta-hydroxyasparagine, 790000177$beta-hydroxyaspartic acid, 790000211$calcium, 790000212$calcium binding, 790000264$cell membrane, 790000334$coated pit, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000481$egf-like domain, 790000496$Endocytosis, 790000616$glycoprotein, 790000679$heterodimer, 790000881$lipoprotein, 790000919$membrane, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor),UP_SEQ_FEATURE[850029122$chain:Low-density lipoprotein receptor-related protein 1 515 kDa subunit, 850029123$chain:Low-density lipoprotein receptor-related protein 1 85 kDa subunit, 850029124$chain:Low-density lipoprotein receptor-related protein 1 intracellular domain, 850044641$chain:Prolow-density lipoprotein receptor- related protein 1, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103598$domain:EGF-like 10, 850103601$domain:EGF-like 11, 850103604$domain:EGF-like 12; calcium-binding, 850103605$domain:EGF-like 13, 850103607$domain:EGF-like 14, 850103609$domain:EGF-like 15, 850103611$domain:EGF-like 16, 850103613$domain:EGF-like 17, 850103615$domain:EGF-like 18, 850103617$domain:EGF-like 19, 850103624$domain:EGF-like 20, 850103626$domain:EGF-like 21, 850103628$domain:EGF-like 22, 850103644$domain:EGF-like 2; calcium-binding, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850103689$domain:EGF-like 5, 850103695$domain:EGF-like 6, 850103698$domain:EGF-like 7, 850103700$domain:EGF-like 8, 850103702$domain:EGF-like 9, 850104665$domain:LDL-receptor class A 1, 850104666$domain:LDL-receptor class A 10, 850104668$domain:LDL-receptor class A 11, 850104669$domain:LDL-receptor class A 12, 850104670$domain:LDL-receptor class A 13, 850104671$domain:LDL-receptor class A 14, 850104672$domain:LDL-receptor class A 15, 850104673$domain:LDL-receptor class A 16, 850104674$domain:LDL-receptor class A 17, 850104675$domain:LDL-receptor class A 18, 850104676$domain:LDL-receptor class A 19, 850104678$domain:LDL-receptor class A 2, 850104679$domain:LDL-receptor class A 20, 850104680$domain:LDL-receptor class A 21, 850104681$domain:LDL-receptor class A 22, 850104682$domain:LDL-receptor class A 23, 850104683$domain:LDL-receptor class A 24, 850104684$domain:LDL-receptor class A 25, 850104685$domain:LDL-receptor class A 26, 850104686$domain:LDL-receptor class A 27, 850104687$domain:LDL-receptor class A 28, 850104688$domain:LDL-receptor class A 29, 850104691$domain:LDL-receptor class A 3, 850104692$domain:LDL-receptor class A 30, 850104693$domain:LDL-receptor class A 31, 850104700$domain:LDL-receptor class A 4, 850104701$domain:LDL-receptor class A 5, 850104703$domain:LDL-receptor class A 6, 850104705$domain:LDL-receptor class A 7, 850104706$domain:LDL-receptor class A 8, 850104707$domain:LDL-receptor class A 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105910$metal ion-binding site:Calcium 1, 850105915$metal ion-binding site:Calcium 1; via carbonyl oxygen, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850105925$metal ion-binding site:Calcium 3, 850105927$metal ion-binding site:Calcium 3; via carbonyl oxygen, 850106258$modified residue, 850106259$mutagenesis site, 850112499$region of interest:Interaction with MAFB, 850116264$repeat:LDL-receptor class B 1, 850116265$repeat:LDL-receptor class B 10, 850116266$repeat:LDL-receptor class B 11, 850116267$repeat:LDL-receptor class B 12, 850116268$repeat:LDL-receptor class B 13, 850116269$repeat:LDL-receptor class B 14, 850116270$repeat:LDL-receptor class B 15, 850116271$repeat:LDL-receptor class B 16, 850116272$repeat:LDL-receptor class B 17, 850116273$repeat:LDL-receptor class B 18, 850116274$repeat:LDL-receptor class B 19, 850116275$repeat:LDL-receptor class B 2, 850116276$repeat:LDL-receptor class B 20, 850116277$repeat:LDL-receptor class B 21, 850116278$repeat:LDL-receptor class B 22, 850116279$repeat:LDL-receptor class B 23, 850116280$repeat:LDL-receptor class B 24, 850116281$repeat:LDL-receptor class B 25, 850116282$repeat:LDL-receptor class B 26, 850116283$repeat:LDL-receptor class B 27, 850116284$repeat:LDL-receptor class B 28, 850116285$repeat:LDL-receptor class B 29, 850116286$repeat:LDL-receptor class B 3, 850116287$repeat:LDL-receptor class B 30, 850116288$repeat:LDL-receptor class B 31, 850116289$repeat:LDL-receptor class B 32, 850116290$repeat:LDL-receptor class B 33, 850116291$repeat:LDL-receptor class B 34, 850116295$repeat:LDL-receptor class B 4, 850116296$repeat:LDL-receptor class B 5, 850116297$repeat:LDL-receptor class B 6, 850116298$repeat:LDL-receptor class B 7, 850116299$repeat:LDL-receptor class B 8, 850116300$repeat:LDL-receptor class B 9, 850117294$sequence conflict, 850117295$sequence variant, 850117444$short sequence motif:Endocytosis signal, 850117681$short sequence motif:Recognition site for proteolytical processing, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
matrix metallopeptidase 14 (membrane-inserted),BIOCARTA[30000257$h_reckPathway:Inhibition of Matrix Metalloproteinases]
matrix metallopeptidase 14 (membrane-inserted),INTERPRO[450000498$IPR000585:Hemopexin/matrixin, 450001611$IPR001818:Peptidase M10A and M12B, matrixin and adamalysin, 450002196$IPR002477:Peptidoglycan binding-like, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450005466$IPR006026:Peptidase, metallopeptidases, 450014617$IPR016293:Peptidase M10A, matrix metallopeotidase, 450016760$IPR018486:Hemopexin/matrixin, conserved site, 450016761$IPR018487:Hemopexin/matrixin, repeat]
matrix metallopeptidase 14 (membrane-inserted),KEGG_PATHWAY[470038883$hsa04912:GnRH signaling pathway]
matrix metallopeptidase 14 (membrane-inserted),PIR_SUPERFAMILY[630001332$PIRSF001191:Peptidase_M10A_matrix]
matrix metallopeptidase 14 (membrane-inserted),SMART[760000105$SM00120:HX, 760000207$SM00235:ZnMc]
matrix metallopeptidase 14 (membrane-inserted),SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790000941$metalloprotease, 790000944$metalloproteinase, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001648$zinc, 790001652$zymogen]
matrix metallopeptidase 14 (membrane-inserted),UP_SEQ_FEATURE[850030637$chain:Matrix metalloproteinase-14, 850102883$disulfide bond, 850104116$domain:Hemopexin-like 1, 850104117$domain:Hemopexin-like 2, 850104118$domain:Hemopexin-like 3, 850104119$domain:Hemopexin-like 4, 850105852$helix, 850106244$metal ion-binding site:Zinc; catalytic, 850106245$metal ion-binding site:Zinc; in inhibited form, 850109636$propeptide:Activation peptide, 850117294$sequence conflict, 850117295$sequence variant, 850117368$short sequence motif:Cysteine switch, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
membrane-associated ring finger (C3HC4) 9,INTERPRO[450010001$IPR011016:Zinc finger, RING-CH-type, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
membrane-associated ring finger (C3HC4) 9,SMART[760000650$SM00744:RINGv]
membrane-associated ring finger (C3HC4) 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000624$golgi apparatus, 790000859$ligase, 790000897$lysosome, 790000919$membrane, 790000937$metal-binding, 790001212$polymorphism, 790001555$transmembrane, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
membrane-associated ring finger (C3HC4) 9,UP_SEQ_FEATURE[850016674$chain:E3 ubiquitin-protein ligase MARCH9, 850102586$compositionally biased region:Pro-rich, 850106259$mutagenesis site, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region, 850118910$zinc finger region:RING-CH-type]
membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide),BIOCARTA[30000112$h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells]
membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide),INTERPRO[450006606$IPR007237:CD20/IgE Fc receptor beta subunit]
membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide),KEGG_PATHWAY[470038871$hsa04664:Fc epsilon RI signaling pathway, 470038914$hsa05310:Asthma]
membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide),OMIM_DISEASE[520000431$Atopy, 520000433$Atopy, susceptibility to]
membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide),SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000759$ige-binding protein, 790000769$immunoglobulin receptor, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001555$transmembrane, 790001556$transmembrane protein]
membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide),UP_SEQ_FEATURE[850023677$chain:High affinity immunoglobulin epsilon receptor subunit beta, 850106258$modified residue, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
microtubule associated serine/threonine kinase-like,COG_ONTOLOGY[90000074$General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
microtubule associated serine/threonine kinase-like,INTERPRO[450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
microtubule associated serine/threonine kinase-like,OMIM_DISEASE[520004829$Thrombocytopenia-2]
microtubule associated serine/threonine kinase-like,SMART[760000115$SM00133:S_TK_X]
microtubule associated serine/threonine kinase-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000446$disease mutation, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
microtubule associated serine/threonine kinase-like,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850031712$chain:Microtubule-associated serine/threonine- protein kinase-like, 850103028$domain:AGC-kinase C-terminal, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
mitochondrial ribosomal protein L43,INTERPRO[450007095$IPR007741:Ribosomal protein/NADH  dehydrogenase domain]
mitochondrial ribosomal protein L43,PIR_SUPERFAMILY[630014018$PIRSF017252:mitochondrial ribosomal protein, L43/L51 types, 630030669$PIRSF500450:mitochondrial ribosomal protein L43]
mitochondrial ribosomal protein L43,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000969$mitochondrion, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001550$transit peptide]
mitochondrial ribosomal protein L43,UP_SEQ_FEATURE[850001788$chain:39S ribosomal protein L43, mitochondrial, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
mitogen-activated protein kinase kinase kinase 6,BIOCARTA[30000180$h_mapkPathway:MAPKinase Signaling Pathway]
mitogen-activated protein kinase kinase kinase 6,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
mitogen-activated protein kinase kinase kinase 6,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway]
mitogen-activated protein kinase kinase kinase 6,PIR_SUPERFAMILY[630029792$PIRSF038174:mitogen activated protein kinase kinase kinase 5/6/15]
mitogen-activated protein kinase kinase kinase 6,SMART[760000193$SM00220:S_TKc]
mitogen-activated protein kinase kinase kinase 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
mitogen-activated protein kinase kinase kinase 6,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850032113$chain:Mitogen-activated protein kinase kinase kinase 6, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
mitogen-activated protein kinase kinase kinase 7 interacting protein 1,BIOCARTA[30000153$h_il1rPathway:Signal transduction through IL1R, 30000200$h_nfkbPathway:NF-kB Signaling Pathway, 30000293$h_tgfbPathway:TGF beta signaling pathway, 30000300$h_tollPathway:Toll-Like Receptor Pathway, 30000313$h_wntPathway:WNT Signaling Pathway]
mitogen-activated protein kinase kinase kinase 7 interacting protein 1,INTERPRO[450001711$IPR001932:Protein phosphatase 2C-related, 450007548$IPR008253:Marvel, 450012637$IPR014045:Protein phosphatase 2C, N-terminal, 450014091$IPR015655:Protein phosphatase 2C]
mitogen-activated protein kinase kinase kinase 7 interacting protein 1,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038862$hsa04620:Toll-like receptor signaling pathway, 470038863$hsa04621:NOD-like receptor signaling pathway]
mitogen-activated protein kinase kinase kinase 7 interacting protein 1,PIR_SUPERFAMILY[630029806$PIRSF038188:mitogen-activated protein kinase kinase kinase 7-interacting protein 1]
mitogen-activated protein kinase kinase kinase 7 interacting protein 1,SMART[760000300$SM00331:PP2C_SIG, 760000301$SM00332:PP2Cc]
mitogen-activated protein kinase kinase kinase 7 interacting protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000825$kinase, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
mitogen-activated protein kinase kinase kinase 7 interacting protein 1,UP_SEQ_FEATURE[850032115$chain:Mitogen-activated protein kinase kinase kinase 7-interacting protein 1, 850102581$compositionally biased region:Poly-Ser, 850105055$domain:PP2C-like, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850118575$strand, 850118624$turn]
myeloid-associated differentiation marker,INTERPRO[450007548$IPR008253:Marvel]
myeloid-associated differentiation marker,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001304$repeat, 790001555$transmembrane]
myeloid-associated differentiation marker,UP_SEQ_FEATURE[850032928$chain:Myeloid-associated differentiation marker, 850104756$domain:MARVEL 1, 850104757$domain:MARVEL 2, 850106258$modified residue, 850117294$sequence conflict, 850118623$transmembrane region]
nuclear distribution gene C homolog (A. nidulans),INTERPRO[450006446$IPR007052:CS domain, 450015774$IPR017447:CS]
nuclear distribution gene C homolog (A. nidulans),PIR_SUPERFAMILY[630002204$PIRSF002076:prolactin-induced T cell protein c15]
nuclear distribution gene C homolog (A. nidulans),SP_PIR_KEYWORDS[790000012$acetylation, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000960$microtubule, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein]
nuclear distribution gene C homolog (A. nidulans),UP_SEQ_FEATURE[850034983$chain:Nuclear migration protein nudC, 850103417$domain:CS, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal]
nudix (nucleoside diphosphate linked moiety X)-type motif 17,INTERPRO[450000072$IPR000086:NUDIX hydrolase domain, 450000073$IPR000086:NUDIX hydrolase, core]
nudix (nucleoside diphosphate linked moiety X)-type motif 17,SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790000899$magnesium, 790000906$manganese, 790000937$metal-binding]
nudix (nucleoside diphosphate linked moiety X)-type motif 17,UP_SEQ_FEATURE[850035295$chain:Nucleoside diphosphate-linked moiety X motif 17, 850104864$domain:Nudix hydrolase, 850106148$metal ion-binding site:Magnesium or manganese, 850117628$short sequence motif:Nudix box]
olfactory receptor, family 2, subfamily L, member 2,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 2, subfamily L, member 2,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 2, subfamily L, member 2,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 2, subfamily L, member 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 2, subfamily L, member 2,UP_SEQ_FEATURE[850035684$chain:Olfactory receptor 2L2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
optineurin,OMIM_DISEASE[520002086$Glaucoma 1, open angle, E, 520002100$Glaucoma, normal tension, susceptibility to]
optineurin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000592$Glaucoma, 790000624$golgi apparatus, 790001162$phosphoprotein, 790001212$polymorphism]
optineurin,UP_SEQ_FEATURE[850036164$chain:Optineurin, 850106258$modified residue, 850112388$region of interest:Interaction with HD, 850112741$region of interest:Interaction with Rab8, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
phosphorylase, glycogen, liver,INTERPRO[450000704$IPR000811:Glycosyl transferase, family 35, 450010659$IPR011833:Glycogen/starch/alpha-glucan phosphorylase]
phosphorylase, glycogen, liver,KEGG_PATHWAY[470038765$hsa00500:Starch and sucrose metabolism, 470038882$hsa04910:Insulin signaling pathway]
phosphorylase, glycogen, liver,OMIM_DISEASE[520002153$Glycogen storage disease VI]
phosphorylase, glycogen, liver,PIR_SUPERFAMILY[630000541$PIRSF000460:glucan phosphorylase, 630000542$PIRSF000460:Pprylas_GlgP]
phosphorylase, glycogen, liver,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000045$allosteric enzyme, 790000232$carbohydrate metabolism, 790000356$complete proteome, 790000446$disease mutation, 790000610$glycogen metabolism, 790000611$glycogen storage disease, 790000619$glycosyltransferase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001283$pyridoxal phosphate, 790001547$transferase]
phosphorylase, glycogen, liver,UP_SEQ_FEATURE[850000229$binding site:AMP, 850022044$chain:Glycogen phosphorylase, liver form, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118388$site:Involved in the association of subunits, 850118409$site:May be involved in allosteric control, 850118575$strand, 850118624$turn]
pleckstrin homology domain containing, family G (with RhoGef domain) member 5,INTERPRO[450000189$IPR000219:Dbl homology (DH) domain, 450001173$IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site, 450001635$IPR001849:Pleckstrin homology, 450014156$IPR015721:Rho GTP exchange factor]
pleckstrin homology domain containing, family G (with RhoGef domain) member 5,OMIM_DISEASE[520004594$Spinal muscular atrophy, distal, autosomal recessive, 4]
pleckstrin homology domain containing, family G (with RhoGef domain) member 5,SMART[760000205$SM00233:PH, 760000294$SM00325:RhoGEF]
pleckstrin homology domain containing, family G (with RhoGef domain) member 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001015$neurodegeneration, 790001162$phosphoprotein, 790001212$polymorphism]
pleckstrin homology domain containing, family G (with RhoGef domain) member 5,UP_SEQ_FEATURE[850039564$chain:Pleckstrin homology domain-containing family G member 5, 850102507$compositionally biased region:Glu-rich, 850102572$compositionally biased region:Poly-Glu, 850103518$domain:DH, 850104979$domain:PH, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
plexin domain containing 2,INTERPRO[450001920$IPR002165:Plexin, 450003205$IPR003659:Plexin/semaphorin/integrin]
plexin domain containing 2,PIR_SUPERFAMILY[630009519$PIRSF010823:Caenorhabditis elegans hypothetical protein C36E8.3]
plexin domain containing 2,SMART[760000369$SM00423:PSI]
plexin domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
plexin domain containing 2,UP_SEQ_FEATURE[850039602$chain:Plexin domain-containing protein 2, 850102605$compositionally biased region:Thr-rich, 850105091$domain:PSI, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
potassium channel tetramerisation domain containing 14,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450002755$IPR003131:Potassium channel, voltage dependent, Kv,  tetramerisation, 450010229$IPR011333:BTB/POZ fold]
potassium channel tetramerisation domain containing 14,SMART[760000197$SM00225:BTB]
potassium channel tetramerisation domain containing 14,SP_PIR_KEYWORDS[790000356$complete proteome]
potassium channel tetramerisation domain containing 14,UP_SEQ_FEATURE[850008475$chain:BTB/POZ domain-containing protein KCTD14, 850103177$domain:BTB]
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13,INTERPRO[450000616$IPR000717:Proteasome component region PCI]
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13,KEGG_PATHWAY[470038819$hsa03050:Proteasome]
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13,PIR_SUPERFAMILY[630019494$PIRSF025015:26S proteasome regulatory subunit]
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13,SMART[760000076$SM00088:PINT]
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001254$proteasome]
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13,UP_SEQ_FEATURE[850001262$chain:26S proteasome non-ATPase regulatory subunit 13, 850104917$domain:PCI, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
rabphilin 3A homolog (mouse),INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450001391$IPR001565:Synaptotagmin, 450002892$IPR003315:Rabphilin-3A effector, zinc-binding, 450009940$IPR010911:Rab-binding domain, 450015781$IPR017455:Zinc finger, FYVE-related, 450016334$IPR018029:C2 membrane targeting protein]
rabphilin 3A homolog (mouse),PIR_SUPERFAMILY[630028413$PIRSF036932:Exophilin]
rabphilin 3A homolog (mouse),SMART[760000211$SM00239:C2]
rabphilin 3A homolog (mouse),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000263$cell junction, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001266$protein transport, 790001304$repeat, 790001475$synapse, 790001558$transport, 790001648$zinc, 790001651$zinc-finger]
rabphilin 3A homolog (mouse),UP_SEQ_FEATURE[850056542$chain:Rabphilin-3A, 850102586$compositionally biased region:Pro-rich, 850103200$domain:C2 1, 850103201$domain:C2 2, 850105137$domain:RabBD, 850106258$modified residue, 850118574$splice variant, 850118819$zinc finger region:FYVE-type]
regulator of G-protein signaling 6,INTERPRO[450000294$IPR000342:Regulator of G protein signalling, 450000504$IPR000591:Pleckstrin/G-protein, interacting region, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014319$IPR015898:G-protein, gamma-like subunit]
regulator of G-protein signaling 6,PIR_SUPERFAMILY[630028460$PIRSF036966:regulator of G protein signaling, RGS7 type]
regulator of G-protein signaling 6,SMART[760000041$SM00049:DEP, 760000196$SM00224:GGL, 760000285$SM00315:RGS]
regulator of G-protein signaling 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001408$Signal transduction inhibitor]
regulator of G-protein signaling 6,UP_SEQ_FEATURE[850057035$chain:Regulator of G-protein signaling 6, 850103515$domain:DEP, 850104021$domain:G protein gamma, 850105178$domain:RGS, 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant, 850118624$turn]
ribosomal RNA processing 12 homolog (S. cerevisiae),INTERPRO[450011654$IPR012978:Region of unknown function, NUC173]
ribosomal RNA processing 12 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
ribosomal RNA processing 12 homolog (S. cerevisiae),UP_SEQ_FEATURE[850058650$chain:RRP12-like protein, 850102507$compositionally biased region:Glu-rich, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
ribosomal modification protein rimK-like family member A,INTERPRO[450004156$IPR004666:S6 modification enzyme RimK, 450010588$IPR011761:ATP-grasp fold, 450012272$IPR013651:ATP-grasp fold, RimK-type, 450012420$IPR013816:ATP-grasp fold, subdomain 2]
ribosomal modification protein rimK-like family member A,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000906$manganese, 790000937$metal-binding, 790001063$nucleotide-binding]
ribosomal modification protein rimK-like family member A,UP_SEQ_FEATURE[850057913$chain:Ribosomal protein S6 modification-like protein A, 850103068$domain:ATP-grasp, 850106174$metal ion-binding site:Manganese 1, 850106177$metal ion-binding site:Manganese 2, 850106263$nucleotide phosphate-binding region:ATP]
similar to CG10103; KIAA0174,INTERPRO[450004530$IPR005061:Protein of unknown function DUF292, eukaryotic]
similar to CG10103; KIAA0174,OMIM_DISEASE[520001144$Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study]
similar to CG10103; KIAA0174,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790001162$phosphoprotein]
similar to CG10103; KIAA0174,UP_SEQ_FEATURE[850026925$chain:IST1 homolog, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112188$region of interest:Interaction with CHMP1A and CHMP1B, 850113022$region of interest:Interaction with VPS37B, 850113026$region of interest:Interaction with VPS4A, VTA1, MITD1 STAMBP and USP8, 850113035$region of interest:Interaction with VTA1, 850117580$short sequence motif:MIT-interacting motif, 850117752$short sequence motif:Type-2 MIT-interacting motif, 850118574$splice variant, 850118624$turn]
similar to cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 2 (PITSLRE proteins),INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
similar to cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 2 (PITSLRE proteins),SMART[760000193$SM00220:S_TKc]
similar to cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 2 (PITSLRE proteins),SP_PIR_KEYWORDS[790000050$alternative initiation, 790000053$alternative splicing, 790000109$Apoptosis, 790000134$ATP, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase]
similar to cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 1 (PITSLRE proteins); cell division cycle 2-like 2 (PITSLRE proteins),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010430$chain:Cell division protein kinase 11A, 850010431$chain:Cell division protein kinase 11B, 850102507$compositionally biased region:Glu-rich, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
small proline-rich protein 3,INTERPRO[450002847$IPR003267:Small proline-rich, 450002880$IPR003302:Cornifin (SPRR)]
small proline-rich protein 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000822$keratinization, 790001212$polymorphism, 790001304$repeat]
small proline-rich protein 3,UP_SEQ_FEATURE[850061044$chain:Small proline-rich protein 3, 850109872$region of interest:14 X 8 AA approximate tandem repeats, 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117294$sequence conflict, 850117295$sequence variant]
solute carrier family 18 (vesicular monoamine), member 2,INTERPRO[450010529$IPR011701:Major facilitator superfamily MFS-1]
solute carrier family 18 (vesicular monoamine), member 2,KEGG_PATHWAY[470038892$hsa05012:Parkinson's disease]
solute carrier family 18 (vesicular monoamine), member 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001027$neurotransmitter transport, 790001162$phosphoprotein, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
solute carrier family 18 (vesicular monoamine), member 2,UP_SEQ_FEATURE[850063163$chain:Synaptic vesicular amine transporter, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118593$topological domain:Lumenal, vesicle, 850118623$transmembrane region]
spastic paraplegia 11 (autosomal recessive),INTERPRO[450016419$IPR018120:Glycoside hydrolase, family 1, active site]
spastic paraplegia 11 (autosomal recessive),OMIM_DISEASE[520004551$Spastic paraplegia-11]
spastic paraplegia 11 (autosomal recessive),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000616$glycoprotein, 790000675$hereditary spastic paraplegia, 790000853$leucine-rich repeat, 790000919$membrane, 790001015$neurodegeneration, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
spastic paraplegia 11 (autosomal recessive),UP_SEQ_FEATURE[850061584$chain:Spatacsin, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
stromal antigen 3,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
stromal antigen 3,INTERPRO[450012342$IPR013721:STAG]
stromal antigen 3,KEGG_PATHWAY[470038835$hsa04114:Oocyte meiosis]
stromal antigen 3,PIR_SUPERFAMILY[630013140$PIRSF016369:PIRSF016369]
stromal antigen 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000317$Chromosome partition, 790000356$complete proteome, 790000915$meiosis, 790001065$nucleus]
stromal antigen 3,UP_SEQ_FEATURE[850011915$chain:Cohesin subunit SA-3, 850102572$compositionally biased region:Poly-Glu, 850102581$compositionally biased region:Poly-Ser, 850105272$domain:SCD, 850117294$sequence conflict, 850118574$splice variant]
suppression of tumorigenicity 7,INTERPRO[450006676$IPR007311:ST7]
suppression of tumorigenicity 7,PIR_SUPERFAMILY[630011303$PIRSF013653:Caenorhabditis elegans hypothetical protein F11A10.5]
suppression of tumorigenicity 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
suppression of tumorigenicity 7,UP_SEQ_FEATURE[850063011$chain:Suppressor of tumorigenicity 7 protein, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
tandem C2 domains, nuclear,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450016334$IPR018029:C2 membrane targeting protein]
tandem C2 domains, nuclear,SMART[760000211$SM00239:C2]
tandem C2 domains, nuclear,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
tandem C2 domains, nuclear,UP_SEQ_FEATURE[850063516$chain:Tandem C2 domains nuclear protein, 850103199$domain:C2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
transcobalamin I (vitamin B12 binding protein, R binder family),INTERPRO[450001914$IPR002157:Cobalamin (vitamin B12)-binding transporter, eukaryotic]
transcobalamin I (vitamin B12 binding protein, R binder family),PIR_SUPERFAMILY[630002534$PIRSF002414:gastric intrinsic factor]
transcobalamin I (vitamin B12 binding protein, R binder family),SP_PIR_KEYWORDS[790000002$3d-structure, 790000338$cobalt, 790000339$cobalt transport, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001558$transport]
transcobalamin I (vitamin B12 binding protein, R binder family),UP_SEQ_FEATURE[850064927$chain:Transcobalamin-1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
transcription factor CP2,INTERPRO[450006955$IPR007604:CP2 transcription factor]
transcription factor CP2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
transcription factor CP2,UP_SEQ_FEATURE[850004777$chain:Alpha-globin transcription factor CP2, 850102485$compositionally biased region:Gln-rich, 850102580$compositionally biased region:Poly-Pro, 850106259$mutagenesis site, 850111458$region of interest:DNA-binding, 850117294$sequence conflict, 850118574$splice variant]
transducin (beta)-like 2,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
transducin (beta)-like 2,OMIM_DISEASE[520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
transducin (beta)-like 2,SMART[760000289$SM00320:WD40]
transducin (beta)-like 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat, 790001640$williams-beuren syndrome]
transducin (beta)-like 2,UP_SEQ_FEATURE[850065724$chain:Transducin beta-like protein 2, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117295$sequence variant]
translocase of outer mitochondrial membrane 40 homolog (yeast),INTERPRO[450001704$IPR001925:Porin, eukaryotic type]
translocase of outer mitochondrial membrane 40 homolog (yeast),KEGG_PATHWAY[470038893$hsa05014:Amyotrophic lateral sclerosis (ALS)]
translocase of outer mitochondrial membrane 40 homolog (yeast),OMIM_DISEASE[520000051$A genome-wide association study for late-onset Alzheimer's disease using DNA pooling, 520002930$Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts]
translocase of outer mitochondrial membrane 40 homolog (yeast),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000798$ion transport, 790000919$membrane, 790000969$mitochondrion, 790000971$mitochondrion outer membrane, 790001220$Porin, 790001266$protein transport, 790001555$transmembrane, 790001558$transport]
translocase of outer mitochondrial membrane 40 homolog (yeast),UP_SEQ_FEATURE[850031953$chain:Mitochondrial import receptor subunit TOM40 homolog, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850118574$splice variant]
tryptophan hydroxylase 1,INTERPRO[450001123$IPR001273:Aromatic amino acid hydroxylase, 450002571$IPR002912:Amino acid-binding ACT, 450005407$IPR005963:Tryptophan 5-monooxygenase, 450016585$IPR018301:Aromatic amino acid hydroxylase, iron/copper binding site, 450018008$IPR019773:Tyrosine 3-monooxygenase-like, 450018009$IPR019774:Aromatic amino acid hydroxylase, C-terminal]
tryptophan hydroxylase 1,KEGG_PATHWAY[470038756$hsa00380:Tryptophan metabolism]
tryptophan hydroxylase 1,PIR_SUPERFAMILY[630000392$PIRSF000336:TH, 630000393$PIRSF000336:tyrosine 3-monooxygenase]
tryptophan hydroxylase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000184$biopterin, 790000356$complete proteome, 790000802$iron, 790000918$melatonin biosynthesis, 790000937$metal-binding, 790000943$metalloprotein, 790000984$Monooxygenase, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001392$serotonin biosynthesis, 790001576$tryptophan catabolism]
tryptophan hydroxylase 1,UP_SEQ_FEATURE[850067012$chain:Tryptophan 5-hydroxylase 1, 850103004$domain:ACT, 850105852$helix, 850106003$metal ion-binding site:Iron, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
tumor necrosis factor receptor superfamily, member 1B,BBID[10000093$72.IAP_interaction_with_cell_death_pathways]
tumor necrosis factor receptor superfamily, member 1B,BIOCARTA[30000298$h_tnfr2Pathway:TNFR2 Signaling Pathway]
tumor necrosis factor receptor superfamily, member 1B,INTERPRO[450001212$IPR001368:TNFR/CD27/30/40/95 cysteine-rich region, 450001340$IPR001507:Endoglin/CD105 antigen]
tumor necrosis factor receptor superfamily, member 1B,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038886$hsa04920:Adipocytokine signaling pathway, 470038893$hsa05014:Amyotrophic lateral sclerosis (ALS)]
tumor necrosis factor receptor superfamily, member 1B,PIR_SUPERFAMILY[630002106$PIRSF001968:tumor necrosis factor receptor type 2]
tumor necrosis factor receptor superfamily, member 1B,SMART[760000181$SM00208:TNFR, 760000213$SM00241:ZP]
tumor necrosis factor receptor superfamily, member 1B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000919$membrane, 790001137$pharmaceutical, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
tumor necrosis factor receptor superfamily, member 1B,UP_SEQ_FEATURE[850067208$chain:Tumor necrosis factor receptor superfamily member 1b, membrane form, 850067237$chain:Tumor necrosis factor-binding protein 2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117108$repeat:TNFR-Cys 1, 850117109$repeat:TNFR-Cys 2, 850117111$repeat:TNFR-Cys 3, 850117113$repeat:TNFR-Cys 4, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ubiquitin specific peptidase 54,INTERPRO[450001239$IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, 450016487$IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site]
ubiquitin specific peptidase 54,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
ubiquitin specific peptidase 54,UP_SEQ_FEATURE[850025699$chain:Inactive ubiquitin carboxyl-terminal hydrolase 54, 850102570$compositionally biased region:Poly-Gln, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
upstream transcription factor 1,BBID[10000073$53.Early-response_Tr_Fac_mast_cells]
upstream transcription factor 1,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450010429$IPR011598:Helix-loop-helix DNA-binding]
upstream transcription factor 1,OMIM_DISEASE[520002442$hyperlipidemia, familial combined, 520002443$Hyperlipidemia, familial combined, susceptibility to]
upstream transcription factor 1,PIR_SUPERFAMILY[630016183$PIRSF019594:upstream stimulatory factor]
upstream transcription factor 1,SMART[760000321$SM00353:HLH]
upstream transcription factor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000449$DNA binding, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
upstream transcription factor 1,UP_SEQ_FEATURE[850099563$chain:Upstream stimulatory factor 1, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850104712$domain:Leucine-zipper, 850105852$helix, 850118575$strand, 850118624$turn]
v-fos FBJ murine osteosarcoma viral oncogene homolog,BBID[10000055$3.T_cell_receptor, 10000087$67.Ikaros_and_signaling_inhibitors, 10000114$92.Ancient_Host_Defense_Pathways]
v-fos FBJ murine osteosarcoma viral oncogene homolog,BIOCARTA[30000023$h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2, 30000036$h_bcellsurvivalPathway:B Cell Survival Pathway, 30000038$h_bcrPathway:BCR Signaling Pathway, 30000045$h_cardiacegfPathway:Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy, 30000052$h_Ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage, 30000057$h_cdMacPathway:Cadmium induces DNA synthesis and proliferation in macrophages, 30000085$h_dreampathway:Repression of Pain Sensation by the Transcriptional Regulator DREAM, 30000091$h_egfPathway:EGF Signaling Pathway, 30000100$h_epoPathway:EPO Signaling Pathway, 30000108$h_etsPathway:METS affect on Macrophage Differentiation, 30000112$h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells, 30000127$h_gleevecpathway:Inhibition of Cellular Proliferation by Gleevec, 30000129$h_gpcrPathway:Signaling Pathway from G-Protein Families, 30000147$h_igf1Pathway:IGF-1 Signaling Pathway, 30000155$h_il2Pathway:IL 2 signaling pathway, 30000156$h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation, 30000157$h_il3Pathway:IL 3 signaling pathway, 30000160$h_il6Pathway:IL 6 signaling pathway, 30000163$h_insulinPathway:Insulin Signaling Pathway, 30000180$h_mapkPathway:MAPKinase Signaling Pathway, 30000201$h_ngfPathway:Nerve growth factor pathway (NGF), 30000222$h_pdgfPathway:PDGF Signaling Pathway, 30000250$h_ranklPathway:Bone Remodelling, 30000287$h_tcrPathway:T Cell Receptor Signaling Pathway, 30000300$h_tollPathway:Toll-Like Receptor Pathway, 30000301$h_TPOPathway:TPO Signaling Pathway, 30000303$h_tsp1Pathway:TSP-1 Induced Apoptosis in Microvascular Endothelial Cell ]
v-fos FBJ murine osteosarcoma viral oncogene homolog,INTERPRO[450000729$IPR000837:Fos transforming protein, 450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010446$IPR011616:bZIP transcription factor, bZIP-1]
v-fos FBJ murine osteosarcoma viral oncogene homolog,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038862$hsa04620:Toll-like receptor signaling pathway, 470038869$hsa04660:T cell receptor signaling pathway, 470038870$hsa04662:B cell receptor signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer]
v-fos FBJ murine osteosarcoma viral oncogene homolog,PIR_SUPERFAMILY[630001865$PIRSF001719:fos transforming protein]
v-fos FBJ murine osteosarcoma viral oncogene homolog,SMART[760000306$SM00338:BRLZ]
v-fos FBJ murine osteosarcoma viral oncogene homolog,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000679$heterodimer, 790000811$isopeptide bond, 790000852$leucine zipper, 790001065$nucleus, 790001162$phosphoprotein, 790001271$Proto-oncogene, 790001543$transcription regulation, 790001592$ubl conjugation]
v-fos FBJ murine osteosarcoma viral oncogene homolog,UP_SEQ_FEATURE[850048670$chain:Proto-oncogene protein c-fos, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict]
vacuolar protein sorting 13 homolog C (S. cerevisiae),COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
vacuolar protein sorting 13 homolog C (S. cerevisiae),INTERPRO[450008641$IPR009543:Vacuolar protein sorting-associated protein]
vacuolar protein sorting 13 homolog C (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000811$isopeptide bond, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
vacuolar protein sorting 13 homolog C (S. cerevisiae),UP_SEQ_FEATURE[850099896$chain:Vacuolar protein sorting-associated protein 13C, 850102554$compositionally biased region:Lys-rich, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
wings apart-like homolog (Drosophila),INTERPRO[450011182$IPR012502:Wings apart-like]
wings apart-like homolog (Drosophila),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000733$host-virus interaction, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
wings apart-like homolog (Drosophila),UP_SEQ_FEATURE[850100899$chain:Wings apart-like protein homolog, 850105696$domain:WAPL, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
xenotropic and polytropic retrovirus receptor,INTERPRO[450003840$IPR004331:SPX, N-terminal, 450003851$IPR004342:EXS, C-terminal]
xenotropic and polytropic retrovirus receptor,PIR_SUPERFAMILY[630028248$PIRSF036764:PIRSF036764]
xenotropic and polytropic retrovirus receptor,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001555$transmembrane]
xenotropic and polytropic retrovirus receptor,UP_SEQ_FEATURE[850101009$chain:Xenotropic and polytropic retrovirus receptor 1, 850103724$domain:EXS, 850105383$domain:SPX, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
zinc finger protein 705G-like,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 705G-like,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 705G-like,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 705G-like,UP_SEQ_FEATURE[850056170$chain:Putative zinc finger protein 705G, 850104552$domain:KRAB, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118721$zinc finger region:C2H2-type 3; degenerate, 850118724$zinc finger region:C2H2-type 4; degenerate]
